Abbott Announces Development of Novel Continuous Glucose-Ketone Monitoring System

/PRNewswire/ -- Abbott (NYSE: ABT) today announced it's developing a new biowearable that will continuously monitor glucose and ketone levels in one sensor....

Related Keywords

United States ,Kansas ,Overland Park ,Aaronj Kowalski ,Jared Watkin ,Kurt Midyett ,Linkedin ,Drug Administration ,Facebook ,National Diabetes Statistics ,Freestyle Libre ,Continuous Glucose Ketone ,Midwest Pediatric Specialists ,Abbott Diabetes ,Diabetes Statistics Report ,Its Burden ,Accessed May ,Ketone Testing ,Patients With Type ,Rev Diabet ,Ketone Monitoring Consensus Report ,Diabetes Science ,Clinical Case ,Ketone Sensor ,Closed Loop Insulin Pump ,Abbott ,